NRF-MOST Joint Grant Call (Infectious Diseases) - Pre-Application

Closes On

27 Nov 2020

Funding Source

External

PI Salary Support

ACP/SDDC Affiliation

Funding Per Grant Amount

S$ 500,000

Qualification

MBBS / BDS / PhD / MD

Academic Appointment

Funding Period

3 years

Citizenship

Foreigner / S / PR

Call Opens

12 Oct 2020

SMC/SDC Registered

Objective
The National Research Foundation of the Republic of Singapore (NRF) and the Ministry of Science and Technology of the People's Republic of China (MOST) signed an Implementation Agreement on Cooperation in Science, Technology and Innovation in 2019, with an aim to advance bilateral cooperation in technology areas of mutual interest, and building on the Agreement on Cooperation in Science and Technology established in 1992 between the Republic of Singapore and the People's Republic of China.
　
The NRF and the MOST will support a joint grant call in the area of vaccines, therapeutics and diagnostics for infectious diseases, including COVID-19. NMRC will oversee the management and implementation of the grant call, including post-award grant administration and management.
　
This joint grant call will support up to 4 projects.

The collaborating teams in Singapore and China will coordinate among themselves to develop a unified and coherent proposal for their collaboration.
　
Please refer to the NMRC website (internet accessible link) for more details on the grant cal

Funding Details

Each project can be funded at up to SGD$500,000 per project (inclusive of 20% indirect costs) for up to 3 years for the Singapore component of the joint project.

Eligibility Criteria

Applicants from Singapore applying as Principal Investigator are required to fulfil the following criteria at the point of application:

Holds a primary appointment in a local publicly funded institution and salaried by the institution.
PIs should have PhD or MD/MBBS/BDS qualifications. (Exceptions would be made on a case-by-case basis).
Is an independent PI with a demonstrated track record of research, as evidenced by the award of nationally competitive funding (international funding to be considered on a case by case basis), substantial publication record in the past 3 years, or PI status in research institutes.
Has a laboratory or clinical research program that carries out research in Singapore
Holds a minimum of 9 months employment (per calendar year) with local Singapore institution(s). Upon award, the PI must agree to fulfil at least 6 months of residency in Singapore for each calendar year over the duration of the grant award.
Has no outstanding report from previous BMRC, NMRC grants, and other national grants.
For proposals involving patients, the PI should be SMC registered; or should be able to demonstrate ability to access patients through SMC registered Co-Is or collaborators.

Submission

Pre-Application Stage:

Only one Principal Investigator (PI) is allowed per application from the Singapore side.

Interested applicants are to submit the completed file ‘NRF-MOST Joint Call_Pre-Application Form (Template)’ as attached through your Host Institution’s Research Office to NMRC Grants Secretariat at MOH_NMRC_Grant@moh.gov.sg by 27 November 2020 (Friday), 5pm.

Both Singapore and China PIs will need to submit their pre-application forms to NMRC and MOST respectively for separate review and evaluation. Please note that this form (attached) is only for applicants from Singapore. The forms for NMRC and MOST are different.

All Pre-Application Forms must be endorsed by PI’s Host Institution’s Director of Research (DOR) (or equivalent). Email endorsement is accepted.

Note: SingHealth PIs are to please refer to your respective Institutional Research Administrators for guidance on internal deadlines and submission procedures set by your institutions.

Contact Person in NMRC